3 Einträge gefunden

1. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

   1. Gontarewicz, Artur
   2. Balabanov, Stefan
   3. von Amsberg, Gunhild
   4. Colombo, Riccardo
   5. Graziano, Alessio
   6. Pesenti, Enrico
   7. Benten, Daniel

   2008 - Forschungsinformationssystem des UKE
2. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

   1. Gontarewicz, Artur
   2. Balabanov, Stefan
   3. von Amsberg, Gunhild
   4. Panse, Jens
   5. Schafhausen, Philippe
   6. Bokemeyer, Carsten
   7. Fiedler, Walter

   2008 - Forschungsinformationssystem des UKE
3. Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative.

   1. Wellbrock, Jasmin
   2. Schultze, Alexander
   3. Schafhausen, Philippe
   4. Otterstetter, Svenja
   5. Dierlamm, Judith
   6. Bokemeyer, Carsten
   7. Brümmendorf, Tim

   2008 - Forschungsinformationssystem des UKE